In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole

The current treatment of trichomoniasis is based on the use of 5-nitroimidazole derivatives. Although metronidazole is reliable, inexpensive and highly effective against anaerobic microorganisms and protozoa, the development of metronidazole-resistant T.vaginalis strains pose to an increasing proble...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Mikrobiyoloji bülteni 2016-01, Vol.50 (1), p.133-139
Hauptverfasser:	Aksoy Gökmen, Ayşegül, Girginkardeşler, Nogay, Kilimcioğlu, Ali Ahmet, Şirin, Mümtaz Cem, Özbilgin, Ahmet
Format:	Artikel
Sprache:	tur
Schlagworte:	2-Pyridinylmethylsulfinylbenzimidazoles - pharmacology Antitrichomonal Agents - pharmacology Cryopreservation Drug Resistance Esomeprazole - pharmacology Humans Metronidazole - pharmacology Ornidazole - pharmacology Parasitic Sensitivity Tests Proton Pump Inhibitors - pharmacology Time Factors Trichomonas vaginalis - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!